Lucid-PSYCH, or LUCID-PSYCH, also known as Lucid-201, is a psychedelic hallucinogen which is under development for the treatment of major depressive disorder.https://www.sec.gov/Archives/edgar/data/1771885/000115752321001089/a52478064_ex991.htm "Lucid’s pipeline includes Lucid-201, a psychedelic drug candidate targeting mental health disorders, [...]" It is under development by Lucid Psycheceuticals. Lucid-PSYCH's exact mechanism of action is undefined. As of March 2023, it is in preclinical research and is progressing to phase 1 clinical trials.
See also List of investigational hallucinogens and entactogens List of investigational antidepressants Lucid-MS
References